Loading company…
Organoid Sciences develops drug platforms using organoids that reproduce human organs.
Founded in 2018 and based in Seongnam, South Korea, Organoid Sciences develops drug discovery and regenerative technologies using organoids. Its work includes organoid-based models of organs such as the pancreas and liver, as well as the ADIO platform for immune assessment and infectious disease analysis. In 2020, it was selected for a stem cell regeneration medical project by the Ministry of Health and Welfare.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in